Guidelines for the diagnosis and treatment of Merkel cell carcinoma - Cutaneous Oncology Group of the French Society of Dermatology

European Journal of Dermatology

Volumn 22, Issue 3, 2012, Pages 375-379

  Boccara, Olivia ^a   Girard, Celine ^b   Mortier, Laurent ^c   Bens, Guido ^d   Saiag, Philippe ^a   Guillot, Bernard ^b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b HÔPITAL SAINT ELOI   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d Porte Madeleine Hospital   (France)

Author keywords

Guidelines; Merkel cell carcinoma; Radiotherapy; Surgery

Indexed keywords

CARBOPLATIN; CD45 ANTIGEN; CHROMOGRANIN A; CYCLOPHOSPHAMIDE; CYTOKERATIN 20; CYTOKERATIN 7; DOXORUBICIN; ETOPOSIDE; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MERKEL CELL TUMOR; METASTASIS; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; RADIATION DOSE; RECURRENCE RISK; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

CARCINOMA, MERKEL CELL; FRANCE; HUMANS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SOCIETIES, MEDICAL;

EID: 84863189087     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1694     Document Type: Article

References (43)

1. Medina-Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: cases series and literature review of 1024 cases. Ann Surg Oncol 2001; 8:204-208.
2. Akhtar S, Ozza KK, Wright J. Merkel cell carcinoma: report of 10 cases and review of the literature. J Am Acad Dermatol 2000; 43:755-767.
3. Gillenwater AM, Hessel AC, Morrisson WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001; 127:149-154.
4. Nghiem P, McKee P, Haynes HA. Merkel cell carcinoma. In: Sober AJ, Haluska FG eds. Skin cancer. Hamilton, Ontario: BC Decker Inc., 2001; 127-141.
5. Bichakjian CK, lowe L, Lao CD, et al. Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management. Cancer 2007; 110:1-12.
6. Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23:2300-2309.
7. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49:832-841.
8. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human MCC. Science 2008; 319:1096-1100.
9. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, et al. NCCN clinical practice guidelines in oncology: Merkel cell carcinoma. J Natl Compr Canc Netw 2009; 7(3):322-332.
10. Becker J, Mauch C, Kortmann RD, Keilholz U, Bootz F, Garbe C, et al. Onkologische leitlini kutanes neuroendokrines karzinom (Merkelkarzinom) Dtsch Dermatol Ges J 2008; 6: S16-18.
11. Boccara O, Girard C, Mortier L, Bens G, Saiag P, Guillot B. Groupe de Cancérologie cutanée de la Société Française de Dermatologie. Ann Dermatol Venereol 2011; 138: 475-482.
12. HAS. Bases méthodologiques pour l'élaboration de recomman-dations professionnelles par consensus formalisé 2006.
13. Cheuk W, Kwan MY, Suster S. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extra-pulmonary small cell carcinomas. Arch Pathol Lab Med 2001; 125:228-231.
14. Hanly AJ, Elgart GW, Jorda M, et al. Analysis of thyroid transcription factor 1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 2000; 27: 118-120.
15. Nicholson SA, McDermott MB, Wick MR. CD 99 and cytokeratin 20 in small cell and basaloid tumors of skin. Applied Immunohistochem Mol Morphol 2000; 8:37-41.
16. Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermpath 1999; 21:16-20.
17. Gruber S, Wilson L. Merkel cell carcinoma. In: Miller SJ, Maloney ME, eds. Cutaneous oncology: pathophysiology, diagnosis, and management. Malden, MA: Blackwell Science, 1998; 710-711.
18. Andea PJ, Zhang ZF, Coit DG. Merkel cell carcinoma. Histological features and prognosis. Cancer 2008; 113: 2549-2558.
19. Ratner D, Nelson BR, Brown MD, et al. Merkel cell carcinoma. J Am Acad Dermatol 1993; 29:143-156.
20. Allen PJ, Zhang Z-F, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999; 229:97-105.
21. Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134:388-393.
22. Skelton HG, Smith KJ, Hitchcock CL, et al. Merkel cell carcinoma analysis of clinical histologic and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997; 37: 734-739.
23. Kokoska ER, Kokoska MS, Collins BT, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997; 174:688-693.
24. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 1995; 21:669-683.
25. Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope 1992; 102:244-249.
26. th edition of the AJCC Cancer staging manual, 2010.
27. Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol; 2010; 63: 751-761.
28. O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997; 23:929-933.
29. Pennington BE, Leffel DJ. Mohs micrographic surgery: established uses and emerging trends. Oncology 2005; 19: 1165-1171.
30. Gupta SGWL, Penas PF, Gellenthin M, Lee SG, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006; 142:685-690.
31. Mehrany K, Otley CC, Weening RH, Phillips PK, Roenigk RK, Nguyen TH. A meta-analysis of the prognosis significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002; 28: 113-117.
32. Allen P, Busam K, Hill AD, Stojadinovic A, Coit D. Immunohisto-chemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 2001; 92: 1650-1655.
33. Su LD, Lowe L, Bradford CR, Yahanda AI, Johnson TM, Sondak VK. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002; 46: 661-666.
34. Wong KC, Zuletta F, Clarke SJ, et al. Clinical management and treatment outcomes of Merkel cell carcinoma. Aust NZ J Surg 1998; 68:354-358.
35. Lewis KGWM, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006; 142:693-700.
36. Veness MJ, Morgan GJ, Gebski V. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005; 27: 208-216.
37. Veness MJ, Perrera L, McCourt J, Shannon J, Hughes TM, Morgan GJ, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg 2005; 75: 275-281.
38. Mortier L, Mirabel X, Fournier C, Piette F, Lartigau E. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 2003; 139:1587-1590.
39. Garneski KM, Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol 2007; 57:166-169.
40. Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroen-docrine/Merkel cell carcinoma of the skin: cases series and review of 204 cases. J Clin Oncol 2000; 18:2493-2499.
41. Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999; 85:2589-2595.
42. Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group study-TROG 96:07. J Clin Oncol 2003; 21:4371-4376.
43. Poulsen MG, Rischin D, Porter I, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Boil Phys 2006; 64:114-119.